Toulouse, France

Thierry Levade

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2017-2021

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Thierry Levade

Introduction

Thierry Levade is a notable inventor based in Toulouse, France. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of five patents to his name, Levade's work focuses on enhancing immune responses in cancer patients.

Latest Patents

Among his latest patents, one is titled "Methods and pharmaceutical compositions for enhancing CD8+ T cell-dependent immune responses in subjects suffering from cancer." This invention relates to methods and pharmaceutical compositions aimed at improving CD8+ T cell-dependent immune responses in cancer patients. Specifically, it involves administering a therapeutically effective amount of an agent that increases intra-tumoral ceramide content. Another significant patent is "Methods and pharmaceutical composition for the treatment of cancer." This invention details a method for enhancing the effectiveness of immune checkpoint inhibitors in cancer treatment by administering a TNFα blocking agent in combination with the inhibitor.

Career Highlights

Levade has worked with prestigious institutions such as the Institut National de la Santé et de la Recherche Médicale and the Centre Hospitalier Universitaire de Toulouse. His research has been pivotal in advancing cancer therapies and improving patient outcomes.

Collaborations

Some of his notable coworkers include Bruno Segui and Nathalie Andrieu-Abadie. Their collaborative efforts have contributed to the success of Levade's research and innovations.

Conclusion

Thierry Levade's work exemplifies the impact of innovative research in the medical field, particularly in cancer treatment. His patents reflect a commitment to enhancing therapeutic strategies and improving the lives of patients suffering from cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…